The aim of the study was to analyze the course and outcome of pregnancies with congenital heart disease of the fetus, diagnosed and terminated at the Institute of gynecology and obstetrics Clinical Center of Serbia over four years. The study included 71 patients, divided into 3 groups according to the fetal outcome. Group 1 had consisted of 9 pregnancies terminated artificially, Group 2 of 48 patients who delivered live fetuses, and Group 3 of 14 pregnancies terminated as fetal intrauterine death. The types congenital heart diseases were categorized as follows: 40 had L-R shunting type, 18 R-L shunting type, 8 coartacion of aorta, and 7 valvular diseases. Intrauterine fetal death occurred in 11 pregnancies in Group 3 after 28 weeks of gestation. In 13 cases karyotypisation were done, because of maternal age or intrauterine growth retardation diagnosed with ultrasound, and 9 of them had genetic disorders. Forty-eight fetuses were born alive. Fourteen died in the first 2-7 days and 12 had successful heart surgery. Twenty-two needed no surgical correction. Ultrasound findings were false negative in 3 cases. The diagnosis of fetal heart disease should be done by fetal echocardiogram, which can be preformed early in the beginning of the pregnancy.
Introduction
Congenital heart disease is one of the most common congenital anomalies. Overall approximately 3% of newborns are found to have some major congenital anomaly, and about one in 6 of these have congenital heart disease. One of five die because of congenital anomalies, and one third of these are cardiovascular abnormalities. The origin of cardiac abnormalities lies in the complex development of the heart. Congenital fetal heart disease is the result of disturbances during embriogenesis. The most common fetal congenital heart diseases are: complete atrioventricular septal defect ("canal" defect), hypoplastic left heart syndrome, double outlet right ventricle and Fallot's tetralogy. Other abnormalities are all much less common than these three. In newborns the most common defect is ventricular septal defect.
Certain groups of pregnant women have been identified as being at special risk of delivering a baby with a heart abnormality. In most cases, the causes of congenital heart disease are unknown. Genetic and environmental factors and lifestyle habits can all be involved. The likelihood of having a child with a congenital heart disease increases if the mother or father, another child, or another relative had congenital heart disease or a family history of sudden death. Viral infections, such as German measles, can produce congenital heart disease. Women with diabetes and phenylketonuria also are at higher risk of having children with congenital heart defects. Many cases of congenital heart disease result from the mother's excessive use of alcohol or taking illegal drugs, such as cocaine, while pregnant. The mother's exposure to certain anticonvulsant and dermatologic drugs during pregnancy also can cause congenital heart disease. There are many genetic conditions, such as Down syndrome, which affect multiple organs and can cause congenital heart disease. It is fortunate that testing is available for pregnancies identified as being at high risk of fetal heart abnormalities. The test, called a fetal echocardiogram, uses the same ultrasound technology that is used for examining the fetal anatomy.
The aim of the study was to analyze the pregnancies involving fetuses with congenital heart disease, diagnosed and terminated at the Institute of gynecology and obstetrics Clinical Center of Serbia over a four-year interval (1999) (2000) (2001) (2002) (2003) . We looked for the fetal and neonatal outcome of these pregnancies. The effort was made to identify any possible known risk factors, to better choose which pregnancies should undergo fetal echocardiographic examinations.
Statistical methods and Experimental Procedures
The study was retrospective and included 71 pregnancies divided into three groups according to the fetal outcome. Group 1 included 9 pregnancies with complex heart diseases that were artificially terminated with agreement of the parents. Group 2 included 48 pregnancies that delivered live newborns. Group 3 included 14 pregnancies that terminated as fetal intrauterine death. Pregnancies were diagnosed and terminated at the Institute of gynecology and obstetrics over a four-year interval. Ultrasound examinations were performed with standard abdominal probes of Toshiba and Acuson machines. We analyzed ultrasound, clinical and histopathology findings of all dead fetuses and newborns. Histopathology analysis was performed by specialists in fetal and neonatal pathology for every stillbirth and artificially terminated fetus, as well as for every newborn that died within the first seven days of life. Patients' age, parity, week of gestation when pregnancy was terminated, maternal diseases in pregnancy (diabetes, hypertension, infection and multiple gestations), kariotyping and the way of termination of pregnancy (cesarean sections, instillations, vaginal spontaneous delivery, labor induction) were analyzed.
Statistical assessment was made by analysis of variance and Hi square test.
Results
Ten patients were younger than 20 years (14%) and 5 were older than 39 (7%). The majority of patients were in no age risk group. That gives special importance to an early prenatal ultrasound and biochemistry screening in the I and II trimesters, which should help diagnose anomalous cases. There was no statistical difference between the groups. (Fx 0.54) Only one pregnancy ended as a fetal intrauterine death before 20 week of gestation. Four fetal deaths occurred in term pregnancies. The incidence of pregnancies that lasted less than 28 week of gestation was 16.9%. Term pregnancies were 54.9%. 49.5% of patients delivered live newborns. The decisions whether to terminate or continue the pregnancy depended on the type of anomaly, the opinion of the team of physicians (perinatologist, neonatologist and surgeon) and parental consent. There is no statistical difference between the groups. (Fx 1.4) Thirty percent of patients had some possible risk factors. 70% belonged to the no risk population; here was no positive family history. 48.9% of all risk factors were multiple gestations. Diabetes was registered in 14.7% of cases and bacterial infection in another 14.7%. Multiple pregnancies are the most frequent risk factor in congenital fetal heart disease. There is no statistical difference between the groups. (Fx 1.4) The incidence of left to right shunt diseases was 57.7%, 25.3% were right to left shunt diseases, 11.2% were anomalies of big blood vessels and 5.6.% were valvular diseases. The categories of congenital heart defects were: ASD 10, VSD 16, Fallot's tetralogy 4, Forman ovale 4, PDA 7, coarctation of aorta 4, pulmonary atresia 1, D transposition 2, hypoplastic left heart 3, combined defects 20. There is no statistical difference between the groups. (Fx 1.4) Genetic analysis was made in 13 cases, and 9 of them had genetic disorders. The incidence of genetic syndromes was 12.6%. The indications for invasive diagnostic procedures were maternal age, pathologic echocardiographic finding and fetal intrauterine growth restriction.
Abnormal ultrasound findings were present in 95% of cases; we found normal ultrasound results in only 3 cases. These babies were born and diagnosis of fetal anomalies was made postnatally. We had only 1% false negative results. The majority of fetuses were boys (56%).
Our study shows that pregnancies with congenital fetal heart diseases have poor outcomes. More than half of them (53%) were terminated artificially or as fetal intrauterine death. Fourteen newborns died in the first 2-7 days after the delivery. Thirty-four newborns survived; of these, 22 babies needed no surgery at all, but 12 received immediate operations.
Discussion
Fesslova V. [1] found that 12% of fetuses with congenital anomalies had congenital heart disease, and 15% of them had genetic anomaly. The incidence of pregnancies terminated with intrauterine fetal death was 10%. One third of newborns died within the first month. 26% of pregnancies were terminated artificially. Fasnacht MS [2] reported that the most common genetic disorders of these fetuses were: trisomy 13, 21 and 18, and micro deletion 22q11 Sy. Boldt T. [3] reported in his study that artificial abortion had an incidence of 35% and that 8% died in uterus. The frequency of genetic disorders was 28%. Half of newborns died within a month. Paladini D. [4] reported that in multiple pregnancies 57% of fetuses with congenital heart disease died after birth and 37% died during or after the cardiac surgery. Shime J. [5] found that congenital heart disease is frequently accompanied with intrauterine growth restriction (37%) and abnormal quantity of amniotic fluid in 26% of cases. Strauss A. [6] detected that every 8 newborns in 1000 had congenital heart disease. The prenatal detection rate was 38%. The most frequent types of heart defects were ASD and VSD; 16% had valvular disease and 11% anomalies of big blood vessels. Premature deliveries were 55%, but 28% did not survive the first year of life. Surgery was performed on 5% of newborns.
In conclusions our study shows that pregnancies with congenital fetal heart diseases have poor outcomes. More than half of them (53%) were terminated artificially or as fetal intrauterine death. Fourteen newborns died in the first 2-7 days after the delivery. Thirtyfour newborns survived, with 22 needing no surgery at all, and 12 receiving immediate operations.
The most interesting thing is the summary of the risk factors where we found high percentages of congenital heart diseases in multiple pregnancies. We suggest performing fetal echocardiography in every such pregnancy.
Assessment of these pregnancies should be done by a team of obstetrician, pediatrician and surgeon, but the ultimate decision for terminating the pregnancy belongs to the parents.
